Trilliant Health

Trilliant Health is a healthcare market intelligence company that provides advanced data analytics solutions aimed at optimizing operational efficiencies and enhancing patient outcomes for healthcare providers in the U. S. Trilliant Health, founded in 2017 and headquartered in Brentwood, US, specializes in healthcare analytics. The company has executed 4 total deals, with its most recent being a Series A funding round on December 4, 2018, where it raised USD 12.

00 mn led by Noro-Moseley Partners, with participation from Martin Ventures, Nashville Capital Network, and NueCura Partners. Devin Carty founded the company, while Hal Andrews serves as the CEO. Trilliant Health specializes in healthcare market intelligence through its suite of comprehensive data analytics products and services. Their primary offerings include data pipelines that capture demand, supply, and yield across the U.

S. health economy, alongside a national provider directory with validated information on 2. 9 million practitioners. The company provides longitudinal patient journey tracking, episodes of care data for 300 million patients, and price transparency insights that reflect negotiated rates for any service nationwide.

By leveraging these products, Trilliant Health aims to address critical use cases such as service line growth, competitive intelligence, patient demand forecasting, and site selection for healthcare providers. Their client base includes health systems, life sciences organizations, ambulatory providers, and health plans, primarily within the United States market, enabling stakeholders to make data-driven decisions that strengthen network integrity and patient retention. Trilliant Health operates on a subscription-based revenue model, offering flexible solutions tailored to the specific needs and workflows of their clients. Transactions typically occur through annual subscriptions or enterprise-level partnerships, where clients gain access to the company's analytics platform and comprehensive datasets.

The company’s flagship products, including their data pipelines and benchmarking tools like the SimilarityIndex™, are integral to these engagements, facilitating insights into market dynamics and patient journeys. Revenue generation is closely tied to the ongoing provision of analytics services, which help healthcare providers optimize operational efficiency, improve patient retention, and enhance service line strategies. Specific pricing plans vary based on the services selected, aligning with the diverse requirements of their clientele while fostering long-term partnerships within the healthcare ecosystem. Trilliant Health is focused on future growth initiatives, including the expansion of its analytics products and the targeting of new healthcare markets.

The company is in the process of designing new tools to enhance its analytics offerings, aiming for market release by 2024. Following their most recent Series A funding on December 4, 2018, which raised USD 12. 00 mn, Trilliant Health plans to allocate these resources towards developing additional products and enhancing their service offerings in both existing and new geographic markets.